A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Alam, Asraful
- Foreign Remittance Income in Bangladesh: Opportunities and Challenges
Authors
1 Department of Business Administration, Daffodil International University, BD
2 ASA University Bangladesh, BD
Source
Asian Business Review, Vol 2, No 2 (2013), Pagination: 22-28Abstract
A remittance is a transfer of money by a foreign worker to his or her home country. Remittance can also refer to the accounting concept of a monetary payment transferred by a customer to a business (Wikipedia, the free encyclopedia). Remittances have been playing a very significant role for the overall economic development of Bangladesh. Therefore, this paper attempts to explore the actual remittance income and its impact on overall economy of Bangladesh. Recently, the world has suffering from the global financial crisis. That is why, the job opportunities are shrinking drastically for the last couple of years. As a result, the government of Bangladesh is now facing tremendous challenges to send people abroad for employment. Thus, this paper also attempts to clearly articulate the opportunities and challenges of remittance income in Bangladesh and suggested some possible courses of action to face these challenges with smart at hand.Keywords
Remittance, Income, Opportunity, Challenge, Bangladesh.- HRM Practices and its Impact on Employee Performance: A Study of the Cement Industry in Bangladesh
Authors
1 Faculty of Business, ASA University, BD
2 ASA University, BD
Source
Global Disclosure of Economics and Business, Vol 2, No 2 (2013), Pagination: 125-132Abstract
In present situation, companies can gain strong competitive advantage through applying effective and efficient human resource practices. If the human resources are managed properly, they can contribute to the success for the company. The effective management of human resource is possible through the implementation of sound HRM practices. The main objective of this research is studying the impact of HRM practices on employee performance in the context of cement industry in Bangladesh. For this purpose the researchers have tried to investigate impact of the various components of HRM practices on employee performance of a sample of 160 employees from seven cement companies listed in the Dhaka Stock Exchange. The data were analyzed by a regression analysis to determine the impact of HRM practices on employee performance. The result shows that training&development and opportunity for career development have a significant positive impact on employee performances. On the other hand, Performance appraisal, Compensation & Benefits, and Leadership Practices have a positive impact on employee performance but the impact is not significant in the context of cement industry in Bangladesh. Moreover, work life balance has a negative impact on employee's performance. Furthermore, efficient management of human resources can increase the performance of the employees of the cement companies in Bangladesh.Keywords
Employees performance, HRM Practices, Performance Appraisal, work life balance, Training and Development, leadership practices, career development etc- Drug Bank:An Update-Resource for in Silico Drug Discovery
Authors
1 Department of Pharmacy, BGC Trust University Bangladesh, Chittagong, BD
Source
Research Journal of Pharmaceutical Dosage Form and Technology, Vol 4, No 3 (2012), Pagination: 166-171Abstract
Drug Bank plays a vital role in the research of bioinformatics/chemo informatics. Drug bank is a richly annotated resource that combines detailed drug data with comprehensive drug target and drug action information. Since its first release in the 2006, Drug Bank has been widely used to facilitate, in silico drug target discovery, drug design, drug docking or screening, drug metabolism prediction, drug interaction prediction and general pharmacological education. First drug bank was released in 2006 with version 1.0. Now it is successfully updated by the releasing of 2.0, 2.5 and 3.0 version. First released in 2006, Drug Bank has become widely used by pharmacists, medicinal chemists, pharmaceutical researchers, clinicians, educators and the general public . The database contains 6707 drug entries including 1436 FDA-approved small molecule drugs, 134 FDA-approved biotech (protein/peptide) drugs, 83 nutraceuticals and 5086 experimental drugs. Additionally, 4228 non-redundant protein (i.e. drug target/enzyme/transporter/carrier) sequences are linked to these drug entries. Each DrugCard entry contains more than 150 data fields with half of the information being devoted to drug/chemical data and the other half devoted to drug target or protein data. Since its last update in 2008, DrugBank has been greatly expanded through the addition of new drugs, new targets and the inclusion of more than 40 new data fields per drug entry (a 40% increase in data 'depth'). These data field additions include illustrated drug-action pathways, drug transporter data, drug metabolite data, pharmacogenomic data, adverse drug response data, ADMET data, pharmacokinetic data, computed property data and chemical classification data. Drug Bank 3.0 also offers expanded database links, improved search tools for drug-drug and food-drug interaction, new resources for querying and viewing drug pathways and hundreds of new drug entries with detailed patent, pricing and manufacturer data. These additions have been complemented by enhancements to the quality and quantity of existing data, particularly with regard to drug target, drug description and drug action data. Drug Bank 3.0 represents the result of 2 years of manual annotation work aimed at making the database much more useful for a wide range of 'Omics' (i.e. pharmacogenomic, pharmacoproteomic, pharmacometabolomic and even pharmacoeconomic) applications.